Dave Muoio

By Dave Muoio 04:00 pm September 22, 2020
The FDA announced today the launch of the Digital Health Center of Excellence, a central resource intended to help the agency as well as external stakeholders promote digital health technologies. Housed within the Center for Devices and Radiological Health (CDRH), the Digital Health Center of Excellence (DHCE) will focus on a range of technologies "mobile health devices, Software as a Medical...
By Dave Muoio 02:54 pm September 21, 2020
Tonal has brought in $110 million from investors, the connected fitness company announced last week. L Catterton, Sapphire Sport, Shasta Ventures, Mayfield, Evolution Media and THVC each renewed their support in the AI-powered exercise-machine service, while new backers included Delta-v Capital, the Amazon Alexa Fund, Mouse Partners and a trio of high-profile athletes – basketball players Stephen...
By Dave Muoio 04:34 pm September 18, 2020
COVID-19 may not be the first pandemic the world has faced, but the virus' challenge comes amidst widespread skepticism of longstanding public health institutions. Government-led responses to outbreaks have varied from country to country, and incongruent messaging between political leaders, health agencies and other sources of information have fueled varying levels of concern and distrust among...
By Dave Muoio 03:35 pm September 17, 2020
The increased adoption of virtual care technologies during the COVID-19 public health emergency is fairly well documented by this point, but a widespread embrace of health technologies is providing a similar upswell on individual niches within the digital health landscape. One such group of beneficiaries are the companies working to develop, validate and distribute digital therapeutics. Speaking...
By Dave Muoio 10:07 am September 17, 2020
Recent investigations of smartphone app-based activity interventions suggested that these approaches have a positive, but not significant, impact on individuals' daily physical activity, according to a recent meta-analysis of published randomized controlled trials (RCTs). Despite the limited gains, the evidence does suggest that the effect differs based on how the interventions are deployed and...
By Dave Muoio 03:35 pm September 16, 2020
Israeli "digital X-ray" company Nanox is fielding increased scrutiny and a sizable hit to its share prices following the publication of a scathing report and commentary that referred to the company as "Theranos 2.0." The criticism was posted yesterday by activist short seller Andrew Left's Citron Research, an online stock analysis and commentary blog that has focused on identifying overpriced or...
By Dave Muoio 03:15 pm September 15, 2020
A new survey conducted among consumers and IT professionals by data security company SecureAge Technology suggests that the clear majority of these groups believe COVID-19 contact-tracing technologies put individuals' personally identifiable information at risk. Despite this, both groups generally believed that these types of tools could help cut down the impact of the disease, and would support...
By Dave Muoio 11:48 am September 15, 2020
Medigate, a startup focused on cybersecurity for medical devices and other connected health products, has announced $30 million in Series B funding, bringing the company's lifetime raise to $50 million. Partech led the round, which also saw participation from Maor Investments and prior backers YL Ventures, U.S. Venture Partners and Blumberg Capital. WHAT IT DOES Medigate's platform secures ...
By Dave Muoio 11:37 am September 14, 2020
Major telehealth vendor MDLive announced this morning a new $50 million crossover equity investment from Sixth Street Growth. The company said that it has also obtained $25 million in debt financing from other unnamed investors. WHAT IT DOES MDLive provides a telehealth platform staffed by a network of certified clinicians capable of delivering virtual urgent care, dermatology, therapy and...
By Dave Muoio 04:53 pm September 11, 2020
International pharma Boehringer Ingelheim and prescription digital therapeutics company Click Therapeutics have inked a $500 million-plus deal to jointly develop and commercialize a digital treatment for patients with schizophrenia. The treatment, referred to as CT-155, will be a mobile app built on Click's proprietary tech platform, the companies said. Employing cognitive and neurobehavioral...